Merck Acquires Novel Neurodegenerative Disease Target With Calporta Buy

 
• By Mandy Jackson
  
Neurodegenerative disease, neural system and memory problems concept 3d rendering. - Illustration
Merck gets a preclinical candidate for neurodegenerative diseases in Calporta deal. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business